Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
 
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82
News
Latest MF Global Business Indian Equities Economy

US takes aim at China in WTO, escalating stakes of trade war

India Infoline News Service Oct-19-2018

The WTO dispute settlement body will consider the US request at its October 29 meeting in Geneva.

Block deals on Friday, October 19, 2018

India Infoline News Service Oct-19-2018

Here are the most pertinent block/bulk deals that took place on the BSE and the NSE on Friday, October 19, 2018.

US stocks rally on boost from earnings; bonds decline

India Infoline News Service Oct-19-2018

The S&P 500 headed for its first weekly gain in a month as strong results from American Express, industrial heavyweight Honeywell, and consumer giant P&G bolstered confidence in the economy.

RBI extends FY19-20 gilts to bridge fiscal deficit

India Infoline News Service Oct-19-2018

The governments latest move might affect the countrys benchmark indices.

What rattled the Indian debt market and how?

India Infoline News Service Oct-19-2018

Many large lenders have blocked their usual credit lines to NBFC borrowers as they believe that such loans could pose bigger challenges in the future.

Govt. slaps anti-dumping duty on some steel products from China

India Infoline News Service Oct-19-2018

This move was mainly to protect domestic players against cheap imports from neighboring countries.

More News
 
Indian Equities News
Latest
Latest

Biocon/Mylan receive positive CHMP opinion for Trastuzumab biosimilar

India Infoline News Service / 20:08, Oct 19, 2018

Biocon/Mylan have already received USFDA approval for Ogvri in the US while they are also expecting European approval for Fulphila.

View all Latest